Background: The underlying mechanism of the association between thyroid function and atrial fibrillation (AF) is poorly understood, but epicardial adipose tissue (EAT) could be a promising mediator. Methods: In the 1995 participants (mean age 64.5 years) from the population-based Rotterdam Study, we measured thyroid function (thyroid-stimulating hormone, free thyroxine [FT4]) and performed computed tomography to quantify EAT volumes. All participants were followed for the occurrence of AF. We assessed associations of thyroid-stimulating hormone and FT4 with EAT and AF and performed causal mediation analysis to decompose the overall effect of thyroid function on AF with EAT as mediator. Results: Higher FT4 levels were associated with larger ...
Atrial fibrillation (AF) is a highly prevalent disorder leading to heart failure, stroke, and death....
Background While adiposity is increasingly recognized as a risk factor for atrial fibrillation (AF),...
PublisherPrevalent atrial fibrillation (AF) in patients with hypertrophic cardiomyopathy (HCM) repre...
Background: The underlying mechanism of the association between thyroid function and atrial fibrilla...
BACKGROUND: Overt and subclinical hyperthyroidism are both well-known independent risk factors for a...
Background: Overt and subclinical hyperthyroidism are both well-known independent risk factors for a...
BACKGROUND: Previous studies have suggested that minor changes in thyroid function are associated wi...
Context: Hyperthyroidism is an established risk factor for atrial fibrillation (AF), but information...
Background: Atrial fibrillation (AF) is a highly prevalent disorder leading to heart failure, strok...
IMPORTANCE Increased free thyroxine (FT4) and decreased thyrotropin are associated with increased ri...
Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with increased cardiovascu...
none7noAbstract Non valvular atrial fibrillation (AF) is the most common ar-rhythmia in I...
Importance: Increased free thyroxine (FT4) and decreased thyrotropin are associated with increased r...
It is well known that hyperthyroidism is one of the most frequent causes of atrial fibrillation. In ...
Obesity is a progressing epidemic, the prevalence of which has doubled over the past 30 years. The d...
Atrial fibrillation (AF) is a highly prevalent disorder leading to heart failure, stroke, and death....
Background While adiposity is increasingly recognized as a risk factor for atrial fibrillation (AF),...
PublisherPrevalent atrial fibrillation (AF) in patients with hypertrophic cardiomyopathy (HCM) repre...
Background: The underlying mechanism of the association between thyroid function and atrial fibrilla...
BACKGROUND: Overt and subclinical hyperthyroidism are both well-known independent risk factors for a...
Background: Overt and subclinical hyperthyroidism are both well-known independent risk factors for a...
BACKGROUND: Previous studies have suggested that minor changes in thyroid function are associated wi...
Context: Hyperthyroidism is an established risk factor for atrial fibrillation (AF), but information...
Background: Atrial fibrillation (AF) is a highly prevalent disorder leading to heart failure, strok...
IMPORTANCE Increased free thyroxine (FT4) and decreased thyrotropin are associated with increased ri...
Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with increased cardiovascu...
none7noAbstract Non valvular atrial fibrillation (AF) is the most common ar-rhythmia in I...
Importance: Increased free thyroxine (FT4) and decreased thyrotropin are associated with increased r...
It is well known that hyperthyroidism is one of the most frequent causes of atrial fibrillation. In ...
Obesity is a progressing epidemic, the prevalence of which has doubled over the past 30 years. The d...
Atrial fibrillation (AF) is a highly prevalent disorder leading to heart failure, stroke, and death....
Background While adiposity is increasingly recognized as a risk factor for atrial fibrillation (AF),...
PublisherPrevalent atrial fibrillation (AF) in patients with hypertrophic cardiomyopathy (HCM) repre...